The healthcare workers of Yale New Haven Health and a growing New Haven drug company were among those honored Tuesday at the Greater New Haven Chamber of Commerce’s Healthcare & Life Sciences awards.
Arvinas, a key tenant of the new life science tower being built at 101 College St., won company of the year in biosciences at the sold-out, in-person event, held at Amarante’s Sea Cliff. Arvinas currently employs 250 people at 5 Science Park and plans to double in size in the next five years, said President and CEO John G. Houston.
“We’re heavily committed to New Haven — our scientists are passionate about living here, they’re passionate about the science and the patients we’re serving,” Houston said.
Yale New Haven Health’s clinical program and medical professionals were awarded for top clinical program due to their ongoing efforts during the COVID-19 pandemic. More than 12,000 COVID-19 sufferers have been successfully discharged from YNHH hospitals so far.
David S. Rosenblum of Gaylord Specialty Healthcare was honored as “industry superstar” for his pioneering efforts in the care of patients with spinal cord injuries.
The “industry visionary” award went to Vlad Coric for his leadership of Biohaven Pharmaceuticals, a company achieving success with its migraine medications.
BIoPath, a partnership between Southern Connecticut State University and the city of New Haven to promote science education, won in the “bioscience innovator” category.
Contact Liese Klein at lklein@newhavenbiz.com.
